Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection 2019
2019 Evaluation of the ELITe InGenius PCR platform for detection of Mycoplasma pneumoniae 2019
2019 Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline 2019
2019 Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infections 2019
2019 Azithromycin-based Extended-Spectrum Antibiotic Prophylaxis for Cesarean: Role of Placental Colonization with Genital Ureaplasmas and Mycoplasmas 2019
2019 Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-Associated mutations in heterosexual african American couples in Alabama 2019
2018 In vitro activities of the benzoquinolizine fluoroquinolone levonadifloxacin (WCK 771) and other antimicrobial agents against mycoplasmas and ureaplasmas in humans, including isolates with defined resistance mechanisms 2018
2018 A rapid and simple chemical method for the preparation of Ag colloids for surface-enhanced Raman spectroscopy using the Ag mirror reaction 2018
2018 Is retained bone debris in cannulated orthopedic instruments sterile after autoclaving? 2018
2018 Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens 2018
2018 High prevalence of multidrug-resistant mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama 2018
2018 Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity 2018
2017 Mycoplasma hominis Infections Transmitted Through Amniotic Tissue Product 2017
2017 Beyond the uterine environment: A nonhuman primate model to investigate maternal-fetal and neonatal outcomes following chronic intrauterine infection 2017
2017 New Horizons in Mycoplasma genitalium Treatment 2017
2017 Mycoplasma pneumoniae from the respiratory tract and beyond 2017
2017 Sequelae of donor-derived mollicutes transmission in lung recipients 2017
2017 In vitro activities of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and China 2017
2017 Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data 2017
2017 Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung Transplantation 2017
2017 Fluorocycline TP-271 is potent against complicated community-acquired bacterial pneumonia pathogens 2017
2017 In vitro activities of gepotidacin (GSK2140944) and other antimicrobial agents against human mycoplasmas and ureaplasmas 2017
2017 Shaken or stirred?: Comparison of methods for dispersion of Mycoplasma pneumoniae aggregates for persistence in vivo 2017
2017 Ureaplasma infection-mediated release of matrix metalloproteinase-9 and PGP: A novel mechanism of preterm rupture of membranes and chorioamnionitis 2017
2016 In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas 2016
2016 Intra-amniotic ureaplasma parvum-induced maternal and fetal inflammation and immune responses in rhesus macaques 2016
2015 Comparative genome analysis of Mycoplasma pneumoniae 2015
2015 Macrolide-resistant Mycoplasma pneumoniae, United States 2015
2015 Specificity and strain-typing capabilities of nanorod array-surface enhanced raman spectroscopy for Mycoplasma pneumoniae detection 2015
2015 Fusobacterium-Positive and Streptococcal-Positive Pharyngitis 2015
2015 Fusobacterium-positive and streptococcal-positive pharyngitis 2015
2015 Sore Throat: Avoid Overcomplicating the Uncomplicated 2015
2015 Sore throat: Avoid overcomplicating the uncomplicated 2015
2015 In Vitro antibacterial activity of AZD0914 against human mycoplasmas and ureaplasmas 2015
2015 Comparison of molecular characteristics of mycoplasma pneumonia specimens collected from the United States and China 2015
2015 Contaminated open fracture and crush injury: A murine model 2015
2015 Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans 2015
2015 Mycoplasma edwardii peritonitis in a patient on maintenance peritoneal dialysis 2015
2015 Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization 2015
2015 The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: A cross-sectional study 2015
2014 Comparison of the illumigene mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae 2014
2014 Mycoplasma pneumoniae infections in childhood 2014
2014 Suppression of antimicrobial peptide expression by Ureaplasma species 2014
2014 Transplacental transfer of azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model 2014
2013 Helicobacter pylori infection inhibits phagocyte clearance of apoptotic gastric epithelial cells 2013
2013 Azithromycin to prevent bronchopulmonary dysplasia in Ureaplasma-infected preterm infants: Pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose 2013
2013 Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms 2013
2013 Antimicrobial susceptibilities and treatment options for pediatric Mycoplasma pneumoniae infections - does macrolide resistance matter? 2013
2012 Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum 2012
2012 Molecular methods for the detection of mycoplasma and ureaplasma infections in humans: A paper from the 2011 William Beaumont Hospital symposium on molecular pathology 2012
2012 Antimicrobial activity of PVP from an Antarctic bacterium, Janthinobacterium sp. Ant5-2, on multi-drug and methicillin resistant Staphylococcus aureus 2012
2012 Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains 2012
2012 Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States 2012
2012 Chronic rectal bleeding due to lymphogranuloma venereum proctocolitis 2012
2012 Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model 2012
2011 What's new in diagnostic testing and treatment approaches for mycoplasma pneumoniae infections in children? 2011
2011 Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis 2011
2011 Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia 2011
2011 Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes 2011
2011 Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants 2011
2011 Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. 2011
2011 Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia 2011
2011 Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia 2011
2011 Stromal regulation of human gastric dendritic cells restricts the Th1 response to helicobacter pylori 2011
2010 Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae 2010
2010 Fusobacterium necrophorum bacteremic tonsillitis: 2 Cases and a review of the literature 2010
2010 Detection of Mycoplasma pneumoniaein simulated and true clinical throat swab specimens by nanorod array-surface-enhanced raman spectroscopy 2010
2010 The use of a biodegradable, load-bearing scaffold as a carrier for antibiotics in an infected open fracture model 2010
2010 Detection and characterization of human Ureaplasma species and serovars by real-time PCR 2010
2010 Human primary gastric dendritic cells induce a Th1 response to H. pylori 2010
2010 Evaluation of vancomycin and daptomycin potency trends (MIC Creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. Medical Centers from 2002 to 2006 (Antimicrobial Agents and Chemotherapy (2009) 53, 10, (4127-4132)) 2010
2009 Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. Medical Centers from 2002 to 2006 2009
2009 Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis 2009
2009 Corrigendum to "Multiple locus variable tandem repeats analysis of meticillin-resistant Staphylococcus aureus discriminates within USA pulsed-field gel electrophoresis types{star, open} [Journal of Hospital Infection 2009; 71: 333-339]" (DOI:10.1016/j.jhin.2008.12.011) 2009
2009 Ureaplasma parvum as a cause of sternal wound infection 2009
2009 Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101 2009
2009 The role of Mycoplasma in upper respiratory infections 2009
2009 Emerging macrolide resistance in mycoplasma pneumoniae in children: Detection and characterization of resistant isolates 2009
2009 Multiple-locus variable-number tandem-repeat analysis of meticillin-resistant Staphylococcus aureus discriminates within USA pulsed-field gel electrophoresis types 2009
2009 Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques 2009
2008 New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections 2008
2008 Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections 2008
2008 Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas 2008
2008 Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a veterans affairs medical center 2008
2008 Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies 2008
2008 Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital 2008
2008 Genital tract methicillin-resistant Staphylococcus aureus: Risk of vertical transmission in pregnant women 2008
2008 Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine 2008
2007 USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections 2007
2007 Ureaplasma Infection and Neonatal Lung Disease 2007
2006 Genotypic characterization of Ureaplasma species by pulsed field gel electrophoresis 2006
2006 Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial 2006
2006 Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center 2006
2006 Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates 2006
2006 Fluoroquinolone resistance in Ureaplasma parvum in the United States 2006
2006 Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder 2006
2006 Influenza testing in the diagnostic laboratory 2006
2005 Effective communication of antimicrobial susceptibility data by pathologists to clinicians 2005
2005 Mycoplasmas and ureaplasmas as neonatal pathogens 2005
2005 Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia 2005
2005 Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas 2005
2005 Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhage 2005
2005 In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis 2005
2005 Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection 2005
2005 Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques 2005
2005 Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies 2005
2005 Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae 2005
2004 Mycoplasma pneumoniae and its role as a human pathogen 2004
2004 Emerging intracellular bacterial infections 2004
2004 The epidemiology of secondary conditions following spinal cord injury 2004
2004 Erratum: Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States: Data from the PROTEKT US surveillance program 2000/2001 (Southern Medical Journal (2003) 96, 10 (974-985)) 2004
2004 Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury 2004
2004 Microbiology of the urethra and perineum and its relationship to bacteriuria in community-residing men with spinal cord injury. 2004
2003 Comparative In Vitro Susceptibilities and Bactericidal Activities of Investigational Fluoroquinolone ABT-492 and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas 2003
2003 Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea 2003
2003 Antimicrobial Resistance among Isolates of Respiratory Tract Infection Pathogens from the Southern United States: Data from the PROTEKT US Surveillance Program 2000/2001 2003
2003 New concepts of Mycoplasma pneumoniae infections in children 2003
2003 Bactericidal activity of levofloxacin against Mycoplasma pneumoniae [3] 2003
2003 Bacillus cereus bacteremia in a preterm neonate 2003
2003 Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America 2003
2003 Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae 2003
2003 Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: Findings of the PROTEKT surveillance study 2003
2003 Vancomycin-resistant enterococci: 15 years and counting 2003
2003 Prevalence of plasmid-mediated quinolone resistance 2003
2003 Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. 2003
2003 In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas 2003
2003 In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas 2003
2003 Ligase chain reaction. 2003
2002 Rhizobium radiobacter bacteremia and its detection in the clinical laboratory 2002
2002 In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials 2002
2001 In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children 2001
2001 Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures 2001
2001 Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes 2001
2001 The value of culture and serology for detection of Mycoplasma pneumoniae infections in the clinical laboratory in the age of molecular diagnostics 2001
2001 Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies 2001
2001 Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee 2001
2001 Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using accuprobe 2001
2001 Bacteremia after spinal cord injury in initial versus subsequent hospitalizations 2001
2000 The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation [2] (multiple letters) 2000
2000 Quantitative analysis of Helicobacter pylori infection in a mouse model 2000
2000 Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice 2000
2000 Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury. 2000
2000 Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children 2000
2000 Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury 2000
2000 Histologic examination of bone marrow core biopsy specimens has limited value in the diagnosis of mycobacterial and fungal infections in patients with the acquired immunodeficiency syndrome 2000
1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens 1999
1999 In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test 1999
1999 Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center 1999
1999 Detection of Chlamydia trachomatis endocervical infections by ligase chain reaction versus ACCESS Chlamydia antigen assay 1999
1999 Comparison of microscan MICroSTREP, PASCO, and sensititre MIC panels for determining antimicrobial susceptibilities of Streptococcus pneumoniae 1999
1999 Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury 1999
1999 No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV-1 infected patients 1999
1998 Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens 1998
1998 Direct bacterial identification from positive BacT/Alert blood cultures using MicroScan overnight and rapid panels 1998
1998 Bactericidal activities of ceftizoxime and cefotaxime against Streptococcus pneumoniae [3] (multiple letters) 1998
1998 Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels 1998
1998 Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by Etest 1998
1998 The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections 1998
1998 Association rules and data mining in hospital infection control and public health surveillance 1998
1998 Bone marrow biopsy and blood culture in evaluating HIV patients [5] (multiple letters) 1998
1998 Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide 1998
1998 Identification of oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus using commercial latex agglutination tests 1998
1998 Immunogenicity of pneumococcal vaccine in persons with spinal cord injury 1998
1998 Research Paper: Association Rules and Data Mining in Hospital Infection Control and Public Health Surveillance. 1998
1997 Spontaneously Colitic C3H/HeJBir Mice Demonstrate Selective Antibody Reactivity to Antigens of the Enteric Bacterial Flora 1997
1997 In vitro activities of cefepime versus cefotaxime and ceftriaxone against penicillin-resistant Streptococcus pneumoniae determined by Etest 1997
1997 In vitro activities of oral antimicrobial agents against penicillin- resistant Streptococcus pneumoniae: Implications for outpatient treatment 1997
1997 Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations 1997
1997 Evaluation of the etest for detection of tetracycline resistance in mycoplasma hominis 1997
1997 Microbiology testing and the pediatrician's office 1997
1997 Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance study 1997
1997 Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance study. 1997
1997 Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: Evidence of a decreased risk of infection 1997
1997 Clinical applications of C-reactive protein in pediatrics 1997
1997 Comparison of long-term renal function after spinal cord injury using different urinary management methods 1997
1997 Detection of Kingella kingae bacteremia and identification of the organism in the clinical laboratory: Experience from two cases 1997
1997 Genotypic investigation of multidrug-resistant Acinetobacter baumannii infections in a medical intensive care unit 1997
1997 Predicting compliance with annual follow-up evaluations in persons with spinal cord injury 1997
1996 Comparative activities of parenteral cephalosporins against penicillin-resistant Streptococcus pneumoniae isolated from pediatric patients 1996
1996 Detection of oxacillin-resistance in staphylococcus aureus by MicroScan MIC panels in comparison to four other methods 1996
1996 In vitro activities of parenteral cephalosporins against penicillin-resistant Streptococcus pneumoniae isolated from pediatric patients 1996
1996 Is sterile water necessary in the water bottle for endoscopic procedures: A prospective clinical and microbiological study 1996
1996 Laboratory diagnosis of mycoplasmal and ureaplasmal infections 1996
1996 Use of sterile compared with tap water in gastrointestinal endoscopic procedures 1996
1995 When to use fluconazole 1995
1995 When to use fluconazole 1995
1995 Compliance with annual urologic evaluations and preservation of renal function in persons with spinal cord injury. 1995
1995 Isolation of Ureaplasma urealyticum from low birth weight infants 1995
1994 Erythromycin lactobionate toxicity in preterm neonates 1994
1994 Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use 1994
1994 Phagocytosis of urinary pathogens in persons with spinal cord injury 1994
1994 Pulmonary infection due to legionella cincinnatiensis in renal transplant recipients: Two cases and implications for laboratory diagnosis 1994
1994 Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection 1994
1993 A quantitative study of genital skin flora in male spinal cord-injured outpatients 1993
1993 Epidemiology and risk factors for urinary tract infection following spinal cord injury 1993
1993 Eradication of urinary tract infection following spinal cord injury 1993
1993 Radiographic Changes Associated with Tracheal Isolation of Ureaplasma Urealyticum from Neonates 1993
1993 Spinal osteomyelitis due to mycobacterium avium-intracellulare in an elderly man with steroid-induced osteoporosis 1993
1993 Systemic Neonatal Infection Due to Ureaplasma urealyticum 1993
1993 Therapeutic Considerations for Ureaplasma urealyticum Infections in Neonates 1993
1993 Ureaplasma urealyticum intrauterine infection: Role in prematurity and disease in newborns 1993
1992 Antibiotic susceptibilities and therapeutic options for ureaplasma urealyticum infections in neonates 1992
1992 Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates 1992
1991 Neurogenic urinary tract infection 1991
1991 Efficacy of clarithromycin against Mycoplasma pneumoniae. 1991
1991 Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum 1991
1991 Efficacy and tolerance of norfloxacinin treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury 1991
1991 In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391 1991
1991 Mycoplasmal infections of cerebrospinal fluid in children undergoing neurosurgery for hydrocephalus 1991
1991 Perinatal mycoplasmal infections 1991
1991 The effects of three serotypes of Ureaplasma urealyticum on spermatozoal motility and penetration in vitro 1991
1991 [525] Pathologic effects of recurrent bacteriuria in patients with spinal cord dysfunction 1991
1990 Ureaplasma and mycoplasma CNS infections in newborn babies 1990
1990 Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice 1990
1990 Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population 1990
1990 Norfloxacin treatment of nosocomial urinary tract infection in patients undergoing intermittent catheterization following spinal cord injury 1990
1989 Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin 1989
1989 Ureaplasma urealyticum infection 1989
1989 Ureaplasma urealyticum pneumonia: Experimental production and demonstration of age-related susceptibility 1989
1989 Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn 1989
1989 Urinary tract infection in spinal cord injury 1989
1988 ASSOCIATION OF UREAPLASMA UREALYTICUM INFECTION OF THE LOWER RESPIRATORY TRACT WITH CHRONIC LUNG DISEASE AND DEATH IN VERY-LOW-BIRTH-WEIGHT INFANTS 1988
1988 CHRONIC UREAPLASMA UREALYTICUM AND MYCOPLASMA HOMINIS INFECTIONS OF CENTRAL NERVOUS SYSTEM IN PRETERM INFANTS 1988
1988 Comparative in vitro activity of norfloxacin in gram-negative urinary tract infections following spinal cord injury 1988
1988 Does Ureaplasma urealyticum cause respiratory disease in newborns? 1988
1988 Genital Mycoplasma infections in neonates 1988
1988 In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones 1988
1987 Isolation of Acholeplasma oculi from human amniotic fluid in early pregnancy 1987
1987 Chronic Recurrent Multifocal Osteomyelitis: Are Mycoplasmas Involved? 1987
1987 Pathogenesis and significance of urogenital mycoplasmal infections. 1987
1986 Role of Ureaplasma urealyticum in amnionitis. 1986
1986 Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy. 1986
1986 Role of ureaplasma urealyticum in amnionitis 1986
1986 Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy 1986
1985 Ureaplasma urealyticum polyarthritis in agammaglobulinemia 1985
1984 Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device 1984
1983 Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. 1983
1983 Association of genital mycoplasmas with exudative vaginitis in a 10-year-old: A case of misdiagnosis 1983
1983 Isolation of mycoplasma hominis and ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: Potential effect on outcome of pregnancy 1983

Chapter

Year Title Altmetric
2015 Mycoplasma.  1076-1085. 2015
2014 Mycoplasmas and Ureaplasmas of Humans.  1587-1609. 2014
2013 Mycoplasma: Curiosity and pathogen.  308-313. 2013
2013 Mycoplasma and ureaplasma.  229-281. 2013
2012 Mycoplasma: Curiosity and pathogen.  308-313. 2012
2010 Mycoplasma.  1145-1156. 2010
2009 Mycoplasma pneumoniae and other human mycoplasmas.  519-541. 2009

Principal Investigator On

  • Comparison Of Commercially Available Diagnostics For The Detection Of Mycoplasma Pneumoniae, Including Macrolide Resistance Determination  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2018 - 2019
  • Private Grant  awarded by WOCKHARDT LTD/PPD 2017 - 2019
  • Sentinel Surveillance for Macrollde-Reslstant Mycoplasma Pneumonlae at Select Sites In the United States  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2017 - 2019
  • Private Grant  awarded by GlaxoSmithKline 2016 - 2017
  • Primate Model of Mid-Gestation Ureaplasma in Utero Infection: Prevention of Neurologic Sequelae  awarded by OREGON HEALTH SCIENCES UNIVERSITY 2012 - 2017
  • Azithromycin to Prevent BPD in Ureaplasma-Infected Preterms: A Multi-Dose PK and Efficacy Trial  awarded by UNIVERSITY OF MARYLAND (BALTIMORE) 2011 - 2017
  • Private Grant  awarded by PARATEK PHARMACEUTICALS, LLC. 2016 - 2017
  • Host-Microbe Cross-Talk and Pregnancy Outcomes  awarded by CINCINNATI CHILDREN'S HOSPITAL 2013 - 2016
  • Private Grant  awarded by IHMA, INC. 2016
  • Private Grant  awarded by CEMPRA PHARMACEUTICALS, INC. 2014 - 2016
  • Private Grant  awarded by NABRIVA THERAPEUTICS AG 2015
  • Private Grant  awarded by CEMPRA PHARMACEUTICALS, INC. 2012 - 2014
  • Supplement to Aetiology of Neonatal Infection in South Asia: Development of a Community-Based Presumptive Clinical Diagnosis Algorithm and Treatment Regimen for Maternal Puerperal Sepsis.  awarded by THE BANGLADESH CHILD HEALTH RESEARCH FOUNDATION 2014
  • Private Grant  awarded by ASTRAZENECA UK LTD 2013 - 2014
  • Private Grant  awarded by MERIDIAN BIOSCIENCE INC. 2012
  • Molecular Epidemiology, Virulence, and Genomic Characterization of Ureaplasmas  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2007 - 2012
  • Teaching Activities

  • PCL1120 - FUNDAMENTALS II (Fall Term 2014) 2014
  • PCL1120 - FUNDAMENTALS II (Fall Term 2014) 2014
  • PCL1120 - FUNDAMENTALS II (Fall Term 2014) 2014
  • PCL1120 - FUNDAMENTALS II (Fall Term 2013) 2013
  • PCL1120 - FUNDAMENTALS II (Fall Term 2013) 2013
  • PCL1120 - FUNDAMENTALS II (Fall Term 2013) 2013
  • PCL1120 - FUNDAMENTALS II (Fall Term 2012) 2012
  • OBHS112 - Fundamentals Dent/Optometry II (Fall Term 2012) 2012
  • PCL1120 - FUNDAMENTALS II (Fall Term 2012) 2012
  • PCL1120 - FUNDAMENTALS II (Fall Term 2011) 2011
  • OBHS121 - Fundamentals of Dent and Opt 2 (Fall Term 2011) 2011
  • PCL1120 - FUNDAMENTALS II (Fall Term 2011) 2011
  • OBHS111 - Fundamentals of Dent and Opt I (Fall Term 2011) 2011
  • PCL1120 - FUNDAMENTALS II (Fall Term 2010) 2010
  • PCL1120 - FUNDAMENTALS II (Fall Term 2010) 2010
  • PCL1120 - FUNDAMENTALS II (Fall Term 2010) 2010
  • PCL1120 - FUNDAMENTALS II (Fall Term 2010) 2010
  • OBHS111 - Fundamentals of Dent and Opt I (Fall Term 2010) 2010
  • STP1099T - SPECIAL TOPIC EXPERIENCE IN PATHOLOGY (Fall Term 2010) 2010
  • PCL1120 - FUNDAMENTALS II (Fall Term 2009) 2009
  • OBHS121 - Fundamentals of Dent and Opt 2 (Fall Term 2009) 2009
  • OPT121L - Ocular Immunology/Micro Lab (Fall Term 2009) 2009
  • OBHS111 - Fundamentals of Dent and Opt I (Fall Term 2009) 2009
  • PAT503R - Remedial General Pathology (Winter Term 2009) 2008 - 2009
  • DENT2131 - General Pathology (Fall Term 2008) 2008
  • CD712 - General Pathology (Fall Term 2008) 2008
  • PAT503L - General Pathology Lab (Fall Term 2008) 2008
  • PAT503O - General Pathology (OPT) (Fall Term 2008) 2008
  • DENT2131 - General Pathology (Fall Term 2007) 2007
  • PAT503L - General Pathology Lab (Fall Term 2007) 2007
  • PAT503O - General Pathology (OPT) (Fall Term 2007) 2007
  • Education And Training

  • UAB Hospital, Internship 1982
  • UAB Hospital, Residency 1986
  • Full Name

  • Ken Waites